Could VR games shield aging brains from Post-Surgery confusion?

NCT ID NCT07641153

Recruiting now Disease control Sponsor: The Methodist Hospital Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial investigates whether playing a virtual reality (VR) cognitive stimulation game can help older adults with mild memory problems stay mentally sharp and avoid delirium after major surgery. Participants, aged 65 and older, will use an Oculus Quest 2 headset for 20 minutes daily to play attention-boosting games. The study will measure how feasible, safe, and acceptable this VR approach is for this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual Reality cognitive stimulation software (ReCognition) delivered via Oculus Quest 2
What this could lead to: If effective, this approach could offer a drug-free way to reduce postoperative delirium and improve recovery in older patients with cognitive decline.
What could go wrong: This is a small early-stage trial focused on feasibility, not yet on proving effectiveness. The VR intervention may not be practical or acceptable for all older patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM DELIRIUM - POSTOPERATIVE SURGERY

Contacts and locations

Locations

Houston Methodist Hospital
RECRUITING

Houston, Texas, 77030, United States
Houston Methodist Research Insititute
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.